Trial Profile
A Study to Evaluate the Long Term Efficacy of Omalizumab in Thai Patients with Severe Asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2020
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 11 Dec 2015 New trial record